Melatonin blocks the activation of estrogen receptor for DNA binding
The DOI matches its Crossref record.
Abstract
The present study shows that melatonin prevents, within the first cell cycle, the estradiol‐induced growth of synchronized MCF7 breast cancer cells. By using nuclear extracts of these cells, we first examined the binding of estradiol–estrogen receptor complexes to estrogen‐responsive elements and found that the addition of estradiol to whole cells activates the binding of the estrogen receptor to DNA whereas melatonin blocks this interaction. By contrast, melatonin neither affects the binding of estradiol to its receptor nor the receptor nuclear localization. Moreover, we also show that addition of estradiol to nuclear extracts stimulates the binding of estrogen receptor to DNA, but this activation is also prevented by melatonin. The inhibitory effect caused by melatonin is saturable at nanomolar concentrations and does not appear to be mediated by RZR nuclear receptors. The effect is also specific, since indol derivatives do not cause significant inhibition. Furthermore, we provide evidence that melatonin does not interact with the estrogen receptor in the absence of estradiol. Together, these results demonstrate that melatonin interferes with the activation of estrogen receptor by estradiol. The effect of melatonin suggests the presence of a receptor that, upon melatonin addition, destabilizes the binding of the estradiol–estrogen receptor complex to the estrogen responsive element.—Rato, A. G., Pedrero, J. G., Martínez, M. A., del Rio, B., Lazo, P. S., Ramos, S. Melatonin blocks the activation of estrogen receptor for DNA binding. FASEB J. 13, 857–868 (1999)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Physiological effects of melatonin: Role of melatonin receptors and signal transduction pathways
PANDIPERUMAL, S., TRAKHT, I., SRINIVASAN, V, SPENCE, D., MAESTRONI, G., ZISAPEL, N., & CARDINALI, D. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.04.001 · Cited by 791
Circadian molecular clocks and cancer
Kelleher, F. C., Rao, A., & Maguire, A. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.09.040 · Cited by 276
Schwertner, A., Conceição dos Santos, C. C., Costa, G. D., Deitos, A., de Souza, A., de Souza, I. C. C., Torres, I. L. S., da Cunha Filho, J. S. L., & Caumo, W. (2013) · Pain · doi:10.1016/j.pain.2013.02.025 · Cited by 155
Circulating melatonin and the risk of breast and endometrial cancer in women
Viswanathan, A. N., & Schernhammer, E. S. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.11.002 · Cited by 153
Urinary Melatonin Levels and Postmenopausal Breast Cancer Risk in the Nurses' Health Study Cohort
Schernhammer, E. S., & Hankinson, S. E. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0637 · Cited by 123
“It is currently thought that melatonin decreases the expression of ERa and hinders the binding of the estradiol-Era complex to the estrogen response element on DNA (9-11), effects that have been shown to be dependent on melatonin binding to specific melatonin (MT1) membrane receptors (which have also been found in bre…”
Metadata
- Authors
- Rato, A. G., Pedrero, J. G., Martínez, M. A., Del Rio, B., Lazo, P. S., & Ramos, S.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 1999-05
- Volume
- 13
- Issue
- 8
- Pages
- 857-868
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1596063300
- Cited by
- 126
- References
- 0
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Melatonin blocks the activation of estrogen receptor for DNA binding. https://app.cochat.ai/papers/10.1096/fasebj.13.8.857
- The paper
- Rato, A. G., Pedrero, J. G., Martínez, M. A., Del Rio, B., Lazo, P. S., & Ramos, S. (1999). Melatonin blocks the activation of estrogen receptor for DNA binding. The FASEB Journal. https://doi.org/10.1096/fasebj.13.8.857
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.